99 related articles for article (PubMed ID: 19069691)
41. Differences in telomerase activity between colon and rectal cancer.
Ayiomamitis GD; Notas G; Zaravinos A; Zizi-Sermpetzoglou A; Georgiadou M; Sfakianaki O; Kouroumallis E
Can J Surg; 2014 Jun; 57(3):199-208. PubMed ID: 24869613
[TBL] [Abstract][Full Text] [Related]
42. Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine.
Lin F; Shi J; Zhu S; Chen Z; Li A; Chen T; Wang HL; Liu H
Arch Pathol Lab Med; 2014 Aug; 138(8):1015-26. PubMed ID: 24437456
[TBL] [Abstract][Full Text] [Related]
43. Postoperative intra-abdominal infection is an independent prognostic factor of disease-free survival and disease-specific survival in patients with stage II colon cancer.
Sánchez-Velázquez P; Pera M; Jiménez-Toscano M; Mayol X; Rogés X; Lorente L; Iglesias M; Gallén M
Clin Transl Oncol; 2018 Oct; 20(10):1321-1328. PubMed ID: 29623587
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
Choi YS; Shim YM; Kim SH; Son DS; Lee HS; Kim GY; Han J; Kim J
Eur J Cardiothorac Surg; 2003 Sep; 24(3):441-9. PubMed ID: 12965318
[TBL] [Abstract][Full Text] [Related]
45. Prognostic impact of microsatellite instability and DNA ploidy in human colon carcinoma patients.
Sinicrope FA; Rego RL; Halling KC; Foster N; Sargent DJ; La Plant B; French AJ; Laurie JA; Goldberg RM; Thibodeau SN; Witzig TE
Gastroenterology; 2006 Sep; 131(3):729-37. PubMed ID: 16952542
[TBL] [Abstract][Full Text] [Related]
46. Expression of p27, COX-2, MLH1, and MSH2 in young patients with colon carcinoma and correlation with morphologic findings.
Kenney B; Deng Y; Mitchell K
Hum Pathol; 2013 Apr; 44(4):591-7. PubMed ID: 23084580
[TBL] [Abstract][Full Text] [Related]
47. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
48. Association between deficient mismatch repair system and efficacy to irinotecan-containing chemotherapy in metastatic colon cancer.
Kim JE; Hong YS; Ryu MH; Lee JL; Chang HM; Lim SB; Kim JH; Jang SJ; Kim MJ; Yu CS; Kang YK; Kim JC; Kim TW
Cancer Sci; 2011 Sep; 102(9):1706-11. PubMed ID: 21679278
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
[TBL] [Abstract][Full Text] [Related]
50. Cell cycle proteins predict recurrence in stage II and III colon cancer.
Belt EJ; Brosens RP; Delis-van Diemen PM; Bril H; Tijssen M; van Essen DF; Heymans MW; Beliën JA; Stockmann HB; Meijer S; Meijer GA
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S682-92. PubMed ID: 22311118
[TBL] [Abstract][Full Text] [Related]
51. Prognostic role of E-cadherin in patients with advanced serous ovarian cancer.
Bačić B; Haller H; Mrklić I; Košta V; Čarić A; Tomić S
Arch Gynecol Obstet; 2013 Jun; 287(6):1219-24. PubMed ID: 23269354
[TBL] [Abstract][Full Text] [Related]
52. Mismatch repair deficiency screening in colorectal carcinoma by a four-antibody immunohistochemical panel in Pakistani population and its correlation with histopathological parameters.
Hashmi AA; Ali R; Hussain ZF; Faridi N; Khan EY; Bakar SMA; Edhi MM; Khan M
World J Surg Oncol; 2017 Jun; 15(1):116. PubMed ID: 28651545
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma.
Losi L; Ponti G; Gregorio CD; Marino M; Rossi G; Pedroni M; Benatti P; Roncucci L; de Leon MP
Pathol Res Pract; 2006; 202(9):663-70. PubMed ID: 16860493
[TBL] [Abstract][Full Text] [Related]
54. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
[TBL] [Abstract][Full Text] [Related]
55. Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis.
Kim SA; Inamura K; Yamauchi M; Nishihara R; Mima K; Sukawa Y; Li T; Yasunari M; Morikawa T; Fitzgerald KC; Fuchs CS; Wu K; Chan AT; Zhang X; Ogino S; Qian ZR
Br J Cancer; 2016 Jan; 114(2):199-206. PubMed ID: 26742007
[TBL] [Abstract][Full Text] [Related]
56. Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer.
Mohan HM; Ryan E; Balasubramanian I; Kennelly R; Geraghty R; Sclafani F; Fennelly D; McDermott R; Ryan EJ; O'Donoghue D; Hyland JM; Martin ST; O'Connell PR; Gibbons D; Winter D; Sheahan K
Eur J Surg Oncol; 2016 Nov; 42(11):1680-1686. PubMed ID: 27370895
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes A and B colon cancer patients undergoing potentially curative surgery.
Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; Romano C; Vollaro M; Agostini B; Pignatelli C; De Vita F
Dis Colon Rectum; 2004 Nov; 47(11):1904-14. PubMed ID: 15622584
[TBL] [Abstract][Full Text] [Related]
58. Impact of microsatellite instability (MSI) on survival in high grade endometrial carcinoma.
Arabi H; Guan H; Kumar S; Cote M; Bandyopadhyay S; Bryant C; Shah J; Abdul-Karim FW; Munkarah AR; Ali-Fehmi R
Gynecol Oncol; 2009 May; 113(2):153-8. PubMed ID: 19275958
[TBL] [Abstract][Full Text] [Related]
59. Association between expression of DNA mismatch repair genes and clinical features and prognosis of patients with radical resection of colon cancer.
Wang JB; Ma DL; Li JY; Sun QD; Liu YE
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706583
[TBL] [Abstract][Full Text] [Related]
60. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
